Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLEASE: Prolonged Antibiotics for Persistent Lyme Disease
NCT01207739Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2010
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of doxycycline, clarithromycin and hydroxychloroquine in Lyme disease, sponsored by Radboud University Medical Center. Started Sep 2010; status: completed.
02
Drugs
doxycyclineclarithromycinhydroxychloroquine
03
Conditions
Lyme disease
Beyond the preview
Go deeper on NCT01207739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01207739.